Inflammatory Breast Cancer
📧 Sign up to get email alerts when something new happens for Inflammatory Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluates carboplatin and paclitaxel with or without panitumumab in invasive triple-negative breast cancer. The stu…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer [Phase 2]
A Phase 2 clinical trial studying whether adding Olaparib to radiation therapy improves outcomes for inflammatory breast cancer; the study i…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer [NA]
This ClinicalTrials.gov entry describes an ongoing study evaluating brain MRI screening in patients with breast cancer, including HER2-posit…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Refining Local-Regional Therapy for IBC [NA]
A Dana-Farber Cancer Institute–led clinical trial is refining local-regional therapy for inflammatory breast cancer and is currently recruit…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma [NA]
A clinical trial evaluating whether lymphovenous bypass performed before axillary lymph node surgery can reduce the risk of lymphedema in pa…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-06Clinical Trial Update: Multi-center MRD Registry for Inflammatory Breast Cancer
A multi-center registry study evaluating minimal residual disease in inflammatory breast cancer, currently recruiting at MD Anderson Cancer …
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: TRUDI: TDXD+Durva in HER2+/Low IBC [Phase 2]
Phase 2 trial TRUDI is evaluating trastuzumab deruxtecan (TDXd) plus durvalumab (Durva) in HER2-positive and HER2-low invasive and inflammat…
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: Study of Immunotherapy in Combination With Chemotherapy in HER2-negative Inflammatory Breast Cancer [Phase 2]
Phase 2 clinical trial update evaluating immunotherapy in combination with chemotherapy for HER2-negative inflammatory breast cancer; the st…
-
CLINICAL_TRIALS research · 2012-07-16Clinical Trial Update: "Phase II Study of PET Guided Neoadjuvant Chemotherapy (NAC) and Oncotype Guided Hormonal Therapy of Breast Cancer" [Phase 2]
Phase II clinical trial evaluating PET-guided neoadjuvant chemotherapy and Oncotype-guided hormonal therapy for breast cancer.
-
CLINICAL_TRIALS research · 2010-04-23Clinical Trial Update: Establishing an Inflammatory Breast Cancer Registry
A completed clinical trial aimed at establishing an inflammatory breast cancer registry, sponsored by the National Cancer Institute, to coll…
-
CLINICAL_TRIALS research · 2007-04-04Clinical Trial Update: Docetaxel, Carboplatin, and Capecitabine as Treatment for Patients With Locally Advanced or Inflammatory Breast Cancer Before Surgery [Phase 2]
A Phase 2 clinical trial evaluating a triple-drug regimen of docetaxel, carboplatin, and capecitabine before surgery for locally advanced or…